Miragen Therapeutics
miRagen is a clinical stage biopharmaceutical company developing innovative microRNA-targeting therapies to improve human health.
3
Funding Rounds
$32.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Sa**** Ma***** | - | - | - |
| Br*** Bo*** | - | - | linkedin twitter facebook |
Funding
Funding series
Funding Series Analysis
The company Miragen Therapeutics has raised a total of $12m in funding over 3 rounds.
Key Insights:
- Miragen Therapeutics Series B round: $4m
- Miragen Therapeutics Series A round: $8m
- Miragen Therapeutics Series B round April 2012: $20m
Miragen Therapeutics Series B round
$4m
Miragen Therapeutics Series A round
$8m
Miragen Therapeutics Series B round April 2012
$20m
Industries
Miragen Therapeutics is active in the following industries: